Banc Funds Co Cut Its Cu Bancorp (CUNB) Position; 17 Analysts Are Bullish Medtronic plc (MDT) Last Week

December 6, 2017 - By Nellie Frank

Banc Funds Co Llc decreased Cu Bancorp (CUNB) stake by 62.82% reported in 2017Q2 SEC filing. Banc Funds Co Llc sold 725,195 shares as Cu Bancorp (CUNB)’s stock declined 7.78%. The Banc Funds Co Llc holds 429,258 shares with $15.52M value, down from 1.15M last quarter. Cu Bancorp now has $668.53M valuation. It closed at $37.5 lastly. It is up 58.83% since December 6, 2016 and is uptrending. It has outperformed by 42.13% the S&P500.

Among 27 analysts covering Medtronic (NYSE:MDT), 17 have Buy rating, 0 Sell and 10 Hold. Therefore 63% are positive. Medtronic had 74 analyst reports since August 10, 2015 according to SRatingsIntel. The firm has “Overweight” rating by Barclays Capital given on Wednesday, November 23. Leerink Swann maintained the shares of MDT in report on Monday, October 9 with “Market Perform” rating. The firm earned “Buy” rating on Wednesday, February 22 by Needham. The stock of Medtronic plc (NYSE:MDT) earned “Hold” rating by Stifel Nicolaus on Tuesday, August 22. The stock has “Overweight” rating by Barclays Capital on Wednesday, August 23. The company was initiated on Monday, April 25 by SunTrust. On Friday, August 26 the stock rating was maintained by UBS with “Buy”. The rating was maintained by UBS on Friday, February 17 with “Buy”. The firm has “Overweight” rating by Morgan Stanley given on Wednesday, March 2. On Friday, August 26 the stock rating was maintained by Needham with “Buy”. See Medtronic plc (NYSE:MDT) latest ratings:

21/11/2017 Broker: Jefferies Rating: Buy New Target: $99.0 Maintain
22/11/2017 Broker: Stifel Nicolaus Rating: Hold New Target: $85.0 Maintain
21/11/2017 Broker: Needham Rating: Buy New Target: $95.0 Maintain
17/11/2017 Broker: SunTrust Rating: Buy New Target: $92.0 Maintain
10/11/2017 Broker: BMO Capital Markets Rating: Buy New Target: $89.0 Maintain
10/10/2017 Broker: BMO Capital Markets Rating: Outperform Old Target: $92 New Target: $87 Maintain
09/10/2017 Broker: Needham Rating: Buy New Target: $94.0 Maintain
09/10/2017 Broker: Leerink Swann Rating: Market Perform Old Target: $88 New Target: $85 Maintain
09/10/2017 Broker: Wells Fargo Old Rating: Outperform New Rating: Market Perform Downgrade
29/09/2017 Broker: BMO Capital Markets Rating: Buy New Target: $92.0 Maintain

Banc Funds Co Llc increased Fnb Bancorp (FNBG) stake by 127,983 shares to 398,950 valued at $10.96M in 2017Q2. It also upped Foresight Financial Group Inc. (FGFH) stake by 25,660 shares and now owns 264,538 shares. First Foundation Inc. (NASDAQ:FFWM) was raised too.

Investors sentiment increased to 1.84 in 2017 Q2. Its up 0.46, from 1.38 in 2017Q1. It improved, as 12 investors sold CUNB shares while 19 reduced holdings. 32 funds opened positions while 25 raised stakes. 8.38 million shares or 12.00% less from 9.52 million shares in 2017Q1 were reported. The Massachusetts-based Panagora Asset Management has invested 0% in CU Bancorp (NASDAQ:CUNB). Goldman Sachs Gp Inc invested in 751,383 shares. Whittier Tru holds 14,575 shares or 0.02% of its portfolio. Virtu Financial Limited Liability Corp owns 19,043 shares. Invesco invested in 28,945 shares. Northern Trust Corporation reported 183,304 shares stake. Citigroup invested 0% of its portfolio in CU Bancorp (NASDAQ:CUNB). Raymond James And Associate invested in 75,100 shares or 0.01% of the stock. California State Teachers Retirement holds 0% in CU Bancorp (NASDAQ:CUNB) or 29,246 shares. Millennium Management Ltd has 0% invested in CU Bancorp (NASDAQ:CUNB). Meeder Asset invested 0% in CU Bancorp (NASDAQ:CUNB). Cardinal Cap Management Ltd Company Ct stated it has 66,114 shares. Sg Americas Ltd Liability Com stated it has 100,401 shares. Alphaone Investment Ltd Liability reported 51,434 shares stake. California Public Employees Retirement Sys owns 23,800 shares.

Among 7 analysts covering CU Bancorp (NASDAQ:CUNB), 4 have Buy rating, 0 Sell and 3 Hold. Therefore 57% are positive. CU Bancorp had 13 analyst reports since October 28, 2015 according to SRatingsIntel. The firm has “Market Perform” rating given on Monday, January 30 by FIG Partners. Piper Jaffray initiated CU Bancorp (NASDAQ:CUNB) on Wednesday, January 18 with “Overweight” rating. The firm earned “Market Perform” rating on Wednesday, October 28 by Hovde Group. The rating was maintained by Keefe Bruyette & Woods on Friday, September 22 with “Buy”. Piper Jaffray maintained CU Bancorp (NASDAQ:CUNB) rating on Monday, July 10. Piper Jaffray has “Buy” rating and $4200 target. The rating was downgraded by Raymond James on Friday, December 16 to “Mkt Perform”. The stock of CU Bancorp (NASDAQ:CUNB) earned “Outperform” rating by Hovde Group on Friday, January 27. Piper Jaffray maintained CU Bancorp (NASDAQ:CUNB) on Monday, August 14 with “Buy” rating. Keefe Bruyette & Woods upgraded the stock to “Outperform” rating in Tuesday, November 29 report. DA Davidson downgraded CU Bancorp (NASDAQ:CUNB) on Friday, April 7 to “Neutral” rating.

Medtronic plc manufactures and sells device medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company has market cap of $109.82 billion. The companyÂ’s Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; diagnostics and monitoring devices; mechanical circulatory support, TYRX, and AF products; and remote monitoring and patient-centered software. It has a 22.06 P/E ratio. It also provides transcatheter heart valves, percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular products, and products to treat superficial and deep venous diseases.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com